Form 4 for OCUL OCULAR THERAPEUTIX, INC
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-22 · accession 0001104659-24-027724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-26 | 2024-02-22 | OCUL | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +80.3K | 180.3K | +80% | $0 |
| D | 2024-02-26 | 2024-02-22 | OCUL | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +244.6K | 244.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | A | A | 80,300 | $0.00 | 180,300 | D | — | — | (F1) On February 22, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal quarterly installments, beginning on the date of grant. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-22 | A | A | 244,550 | $0.00 | 244,550 | D | $9.70 · — to 2024-02-21 | 244,550 Common Stock | (F2) Vests over four years, with 1/4 of the shares underlying the option vesting on the one-year anniversary of the date the reporting person commenced employment with the Corporation and 1/48 of the shares underlying the option vesting monthly thereafter. |